Italy's Farmindustria warning on fake drugs

29 April 2009

Italy's research-based pharmaceutical association, Farmindustria, has welcomed social research institute the Censis' publication of data  concerning the risk of counterfeit medicines in the country. Although  the estimated fake drug market is estimated to be only 0.1%, people are  also at risk from the unsupervised on-line purchase of prescription  agents, with anabolic steroids considered to be a particular problem.

Welfare Undersecretary Ferruccio Fazio, speaking at a conference  organized by the Censis, announced a 60.0-million-euro ($78.8 million)  program to monitor pharmacies and sports centers to evaluate the extent  of prescription drug abuse in the country.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight